Preview Mode Links will not work in preview mode

Evidence Based Medicine presented by InpharmD™

  1. All Episodes
  2. Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation for COVID-19 Patients

Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation for COVID-19 Patients

Apr 16, 2021

A randomized, open-label, trial conducted to evaluate the effects of intermediate-dose vs standard-dose prophylactic anticoagulation among patients with COVID-19 admitted to the intensive care unit (ICU).